{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:49:36Z","timestamp":1791298176097,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03633-5","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T05:19:29Z","timestamp":1756185569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study"],"prefix":"10.1186","volume":"27","author":[{"given":"Katsuhide","family":"Kusaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Todoroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"3633_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.amjcard.2017.01.015","volume":"119","author":"A Ogawa","year":"2017","unstructured":"Ogawa A, Satoh T, Tamura Y, Fukuda K, Matsubara H. Survival of Japanese patients with idiopathic\/heritable pulmonary arterial hypertension. Am J Cardiol. 2017;119:1479\u201384.","journal-title":"Am J Cardiol"},{"key":"3633_CR2","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/rheumatology\/kes140","volume":"51","author":"Y Shirai","year":"2012","unstructured":"Shirai Y, Yasuoka H, Okano Y, Takeuchi T, Satoh T, Kuwana M. Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology. 2012;51:1846\u201354.","journal-title":"Rheumatology"},{"key":"3633_CR3","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RM, Brida M, et al. 2022ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"6","key":"3633_CR4","doi-asserted-by":"publisher","first-page":"2102334","DOI":"10.1183\/13993003.02334-2021","volume":"59","author":"R Naeije","year":"2022","unstructured":"Naeije R, Richter MJ, Rubin LJ. The physiological basis of pulmonary arterial hypertension. Eur Respir J. 2022;59(6):2102334.","journal-title":"Eur Respir J"},{"key":"3633_CR5","doi-asserted-by":"publisher","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","volume":"53","author":"A Frost","year":"2019","unstructured":"Frost A, Badesch D, Gibbs JS, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53:1801904.","journal-title":"Eur Respir J"},{"key":"3633_CR6","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/eurheartj\/ehr160","volume":"32","author":"EM Lau","year":"2011","unstructured":"Lau EM, Manes A, Celermajer DS, Gali\u00e8 N. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J. 2011;32:2489\u201398.","journal-title":"Eur Heart J"},{"key":"3633_CR7","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1038\/s41598-022-09353-z","volume":"12","author":"A Guill\u00e9n-Del-Castillo","year":"2022","unstructured":"Guill\u00e9n-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Gim\u00e9nez BS, Colunga-Arg\u00fcelles D, Revilla-L\u00f3pez E, et al. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension. Sci Rep. 2022;12:5289.","journal-title":"Sci Rep"},{"issue":"4","key":"3633_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/rheumatology\/kead360","volume":"63","author":"O Distler","year":"2024","unstructured":"Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, St\u00e4hler G, et al. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis. Rheumatology (Oxford). 2024;63(4):1139\u201346.","journal-title":"Rheumatology (Oxford)"},{"key":"3633_CR9","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3899\/jrheum.100245","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Air\u00f2 P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37:2290\u20138.","journal-title":"J Rheumatol"},{"key":"3633_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1378\/chest.09-1140","volume":"137","author":"DB Badesch","year":"2010","unstructured":"Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137:376\u201387.","journal-title":"Chest"},{"key":"3633_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jacc.2019.10.048","volume":"75","author":"JE Ho","year":"2020","unstructured":"Ho JE, Zern EK, Lau ES, Wooster L, Bailey CS, Cunningham T, et al. Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort. J Am Coll Cardiol. 2020;75:17\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3633_CR12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3633_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1164\/rccm.201402-0269PP","volume":"190","author":"G Kovacs","year":"2014","unstructured":"Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med. 2014;190(3):252\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3633_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.119.040295","volume":"140","author":"R Naeije","year":"2019","unstructured":"Naeije R, Chin K. Differentiating precapillary from postcapillary pulmonary hypertension. Circulation. 2019;140(9):712\u20134.","journal-title":"Circulation"},{"issue":"3","key":"3633_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.202311-2037ED","volume":"209","author":"R Naeije","year":"2024","unstructured":"Naeije R, Tonelli AR. Pulmonary artery wedge pressure in the diagnosis of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2024;209(3):242\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"3633_CR16","doi-asserted-by":"publisher","first-page":"2103181","DOI":"10.1183\/13993003.03181-2021","volume":"60","author":"K Zeder","year":"2022","unstructured":"Zeder K, Banfi C, Steinrisser-Allex G, Maron BA, Humbert M, Lewis GD, et al. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review. Eur Respir J. 2022;60:2103181.","journal-title":"Eur Respir J"},{"issue":"3","key":"3633_CR17","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","volume":"19","author":"V Smith","year":"2020","unstructured":"Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with raynaud\u2019s phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19(3):102458.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"3633_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41584-021-00685-0","volume":"17","author":"M Cutolo","year":"2021","unstructured":"Cutolo M, Smith V. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases. Nat Rev Rheumatol. 2021;17(11):665\u201377.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"3633_CR19","doi-asserted-by":"publisher","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","volume":"18","author":"V Smith","year":"2019","unstructured":"Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, et al. Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern. Autoimmun Rev. 2019;18(11):102394.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"3633_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","volume":"27","author":"JJ Atherton","year":"2018","unstructured":"Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, et al. National heart foundation of Australia and cardiac society of Australia and new zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ. 2018;27(10):1123\u2013208.","journal-title":"Heart Lung Circ"},{"issue":"9","key":"3633_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, Evidence-Based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861\u201370.","journal-title":"Circulation"},{"issue":"36","key":"3633_CR22","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"4","key":"3633_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1183\/09031936.00091212","volume":"42","author":"BD Fox","year":"2013","unstructured":"Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J. 2013;42(4):1083\u201391.","journal-title":"Eur Respir J"},{"issue":"4","key":"3633_CR24","doi-asserted-by":"publisher","first-page":"2401344","DOI":"10.1183\/13993003.01344-2024","volume":"64","author":"BA Maron","year":"2024","unstructured":"Maron BA, Bortman G, De Marco T, Huston JH, Lang IM, Rosenkranz SH, et al. Pulmonary hypertension associated with left heart disease. Eur Respir J. 2024;64(4):2401344.","journal-title":"Eur Respir J"},{"key":"3633_CR25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Gr\u00fcnig E, Bonderman D, Distler O, Khanna D, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73:1340\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3633_CR26","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"38","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E, Steen VD, PHAROS Investigators. Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol. 2011;38:2172\u20139.","journal-title":"J Rheumatol"},{"key":"3633_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/25785826.2018.1531189","volume":"41","author":"S Kubo","year":"2018","unstructured":"Kubo S, Smith V, Cutolo M, Tanaka Y. The role of nailfold videocapillaroscopy in patients with systemic sclerosis. Immunol Med. 2018;41:113\u20139.","journal-title":"Immunol Med"},{"issue":"5","key":"3633_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1183\/09031936.00025607","volume":"30","author":"S Huez","year":"2007","unstructured":"Huez S, Roufosse F, Vachi\u00e9ry JL, Pavelescu A, Derumeaux G, Wautrecht JC, et al. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J. 2007;30(5):928\u201336.","journal-title":"Eur Respir J"},{"issue":"1","key":"3633_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chest.2018.01.022","volume":"154","author":"R Naeije","year":"2018","unstructured":"Naeije R, Saggar R, Badesch D, Rajagopalan S, Gargani L, Rischard F, et al. Exercise-Induced pulmonary hypertension: translating pathophysiological concepts into clinical practice. Chest. 2018;154(1):10\u20135.","journal-title":"Chest"},{"key":"3633_CR30","doi-asserted-by":"publisher","first-page":"1477562","DOI":"10.3389\/fspor.2024.1477562","volume":"6","author":"A Coulis","year":"2024","unstructured":"Coulis A, Levanon S, Randhawa G, Brailovsky Y, Raza F, Oliveros E. Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Front Sports Act Living. 2024;6:1477562.","journal-title":"Front Sports Act Living"},{"issue":"36","key":"3633_CR31","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","volume":"43","author":"vascular disease in","year":"2022","unstructured":"vascular disease in. Pulmonary hypertension due to left heart disease: pathophysiologic implications. Eur Heart J. 2022;43(36):3417\u201331.","journal-title":"Eur Heart J"},{"key":"3633_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jdermsci.2009.03.004","volume":"55","author":"M Jinnin","year":"2009","unstructured":"Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Retrospective study of clinical and laboratory features in Japanese scleroderma patients with cardiac involvement. J Dermatol Sci. 2009;55:70\u20132.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"3633_CR33","doi-asserted-by":"publisher","first-page":"13358","DOI":"10.1038\/s41598-024-63823-0","volume":"14","author":"Y Kanazawa","year":"2024","unstructured":"Kanazawa Y, Goda A, Mohri T, Takeuchi S, Takeuchi K, Kikuchi H, et al. Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines. Sci Rep. 2024;14(1):13358.","journal-title":"Sci Rep"},{"key":"3633_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.00008611","volume":"39","author":"G Kovacs","year":"2012","unstructured":"Kovacs G, Olschewski A, Berghold A, Olschewski H. Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J. 2012;39:319\u201328.","journal-title":"Eur Respir J"},{"issue":"18","key":"3633_CR35","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"10458","key":"3633_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","volume":"404","author":"PS Jhund","year":"2024","unstructured":"Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, et al. Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet. 2024;404(10458):1119\u201331.","journal-title":"Lancet"},{"key":"3633_CR37","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/rheumatology\/kez244","volume":"58","author":"S Kubo","year":"2019","unstructured":"Kubo S, Nakayamada S, Miyazaki Y, Yoshikawa M, Yoshinari H, Satoh Y, et al. Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis. Rheumatol (Oxf Engl). 2019;58:2273\u201383.","journal-title":"Rheumatol (Oxf Engl)"},{"key":"3633_CR38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00101-004-0713-1","volume":"53","author":"H Wilkens","year":"2004","unstructured":"Wilkens H. Pulmonale hypertonie. Pathophysiologie und Aktuelle medikament\u00f6se therapiekonzepte [Pulmonary hypertension. Pathophysiology and current concepts of medication therapy]. Anaesthesist. 2004;53:734\u201340.","journal-title":"Anaesthesist"},{"key":"3633_CR39","unstructured":"Bournia VK, Kottas K, Panopoulos S, Konstantonis G, Iliopoulos A, Tektonidou MG, et al. Differential performance of nailfold video capillaroscopic parameters in the diagnosis and prognosis of systemic sclerosis. Clin Exp Rheumatol. 2020 May-Jun;38(125):29\u201339. Epub 2020 Jan 14."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03633-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:37:39Z","timestamp":1757464659000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3633"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03633-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained consent from all patients to conduct various clinical tests. This study was conducted in compliance with the Declaration of Helsinki. Informed consent was obtained from all patients while utilising anonymised data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S. Kubo has received speaking fees from Eli Lilly, GlaxoSmithKline, Bristol-Myers, Abbvie, Eisai, Pfizer, Astra-Zeneca and also research grants from Daiichi-Sankyo, Abbvie, Boehringer Ingelheim, and Astellas. S. Nakayamada has received consulting fees, speaking fees, lecture fees, and\/or honoraria from AstraZeneca, GlaxoSmithKline, Pfizer, Bristol-Myers, Astellas, Asahi-Kasei, AbbVie, Chugai, Sanofi, Eisai, Gilead Sciences, Mitsubishi-Tanabe, Janssen, Eli Lilly, Boehringer Ingelheim and Ayumi. Y. Miyazaki has received consulting fees, speaking fees, lecture fees, and\/or honoraria from AstraZeneca, GlaxoSmithKline, Bristol-Myers, Astellas, Asahi-Kasei, AbbVie, Chugai, Sanofi, Eisai, Eli Lilly, and Boehringer Ingelheim. M. Ueno has received speaking fees from GlaxoSmithKline. Y. Tanaka has received speaking fees and\/or honoraria from Gilead, Abbvie, Behringer-Ingelheim, Eli Lilly, Mitsubishi-Tanabe, Chugai, Amgen, YL Biologics, Eisai, Astellas, Bristol-Myers, and Astra-Zeneca; received research grants from Asahi-Kasei, Abbvie, Chugai, Mitsubishi-Tanabe, Eisai, Takeda, Corrona, Daiichi-Sankyo, Kowa, and Behringer-Ingelheim; and received consultant fees from Eli Lilly, Daiichi-Sankyo, Taisho, Ayumi, Sanofi, GSK, and Abbvie. The other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}